Aggregator

Science, Volume 390, Issue 6779, Page 1259-1265, December 2025.

Science, Volume 390, Issue 6779, Page 1266-1271, December 2025.

Science, Volume 390, Issue 6779, Page 1305-1309, December 2025.

Science, Volume 390, Issue 6779, Page 1254-1258, December 2025.

Science, Volume 390, Issue 6779, Page 1237-1237, December 2025.

Science, Volume 390, Issue 6779, Page 1236-1236, December 2025.

A mix of Science’s most loved and most read items of the year

Cells in the guts of female mice respond to estrogen by increasing pain signaling, researchers find

Clean energy infrastructure is being deployed with unmatched scale and speed—and China is leading the way

Right-wing politician José Antonio Kast has promised to slash government spending

Ferroelectrics could bolster “flash” memory in AI data centers and autonomous robots

CONCLUSION: In healthy older adults, a single session of tDCS designed to modulate DAN and DN excitability concurrently improved gait speed in both single and dual-task walking, as well as working memory. These preliminary findings suggest that gait and working memory may be modifiable through neuromodulation approaches involving DAN and DN. Further studies are warranted to explore the relationship between gait, working memory, and these two brain networks using neuroimaging means.

No abstract

Synaptic loss is a hallmark of Alzheimer's disease (AD) but lacks robust blood-based biomarkers. We investigate growth-associated protein 43 (GAP-43), previously identified as a synaptic candidate in the cerebrospinal fluid (CSF). Postmortem proteomic profiling of brain-derived extracellular vesicles (n = 21) highlights GAP-43 as a central hub within synaptic protein networks co-depleted in AD and closely linked with proteins enriched in immune-, metabolic-, and synaptic-related modules. In two...

Glucagon-like peptide-1 (GLP-1) medicines are used for the treatment of type 2 diabetes (T2D) and obesity and reduce rates of cardiovascular disease, including stroke, in people with T2D. Substantial evidence from real-world data and clinical trials highlights the therapeutic potential of GLP-1 medicines for the treatment of neurodegenerative disorders such as Parkinson's and Alzheimer's diseases. Similarly, there is growing evidence for the potential utility of using GLP-1 medicines to reduce...

The prevalence of Alzheimer's disease neuropathological changes (ADNCs), the leading cause of cognitive impairment, remains uncertain. Recent blood-based biomarkers enable scalable assessment of ADNCs¹. Here we measured phosphorylated tau at threonine 217 in 11,486 plasma samples from a Norwegian population-based cohort of individuals over 57 years of age as a surrogate marker for ADNCs. The estimated prevalence of ADNCs increased with age, from less than 8% in people 58-69.9 years of age to...

Circulating metabolites can identify biochemical risk factors related to Alzheimer's disease (AD). We measured plasma metabolites in 1,068 participants of Caribbean Hispanic ancestry (250 patients with AD and 818 healthy controls) across 2 cohorts and analyzed their relationship with clinical AD, biomarker-supported AD and plasma biomarkers (P-tau181, P-tau217, P-tau231 and Aβ42:Aβ40). Amino acid metabolism pathways were enriched among metabolites associated with P-tau biomarkers, whereas sialic...

No abstract

Tau is a microtubule-associated cytoskeletal protein, which, when hyperphosphorylated and aggregated, can result in a myriad of different tauopathies, including Alzheimer's disease (AD). We previously showed that the principal component of senile plaques, amyloid beta (Aβ), is an antimicrobial peptide capable of binding and entrapping microbial pathogens. Here we show that tau is hyperphosphorylated in neurons in response to viral infection and can neutralize herpes simplex virus 1 (HSV-1)...

Aging is a natural physiological process that may be accompanied by pathological changes, particularly in the brain. Iron is an essential trace element supporting various physiological functions and maintaining cellular homeostasis. However, iron levels tend to increase in certain brain regions of older adults and are associated with the development of neurodegenerative diseases. Despite this association, the causal relationship between aging, iron accumulation, and neurodegenerative diseases...